4.2 β-AR receptor blockers, via β2-AR, inhibit lipid-induced macrophage differentiation from M1-like phenotype to M2-like phenotype and inhibit atherosclerosis progression (Zhang et al., 2023). Here, ADRB2 is linked to atherosclerosis.